FFA
GILD icon

Fi3 Financial Advisors’s Gilead Sciences GILD Stock Holding History

Fi3 Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Buy
2,995
+446
+17% +$62.5K 0.12% 91
2025
Q4 		$313K Buy
2,549
+271
+12% +$32.9K 0.1% 123
2025
Q3 		$253K Sell
2,278
-180
-7% -$20.5K 0.09% 119
2025
Q2 		$273K Buy
2,458
+3
+0.1% +$319 0.1% 107
2025
Q1 		$275K Buy
2,455
+69
+3% +$7.12K 0.11% 88
2024
Q4 		$220K Buy
+2,386
New +$215K 0.08% 110

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fi3 Financial Advisors's GILD Position: Q1 2026 in Review

Fi3 Financial Advisors increased its Gilead Sciences (GILD) stake by 17% in Q1 2026, buying an estimated $62.5K and bringing the position to 2,995 shares worth $417K. The position accounts for 0.12% of the portfolio, ranked #91.

Fi3 Financial Advisors first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Fi3 Financial Advisors held 2,995 shares of Gilead Sciences worth $417K as of Q1 2026.
  • Fi3 Financial Advisors bought 446 Gilead Sciences shares in Q1 2026, an estimated $62.5K.
  • Gilead Sciences made up 0.12% of Fi3 Financial Advisors's portfolio in Q1 2026, its #91 holding.
  • Fi3 Financial Advisors first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Fi3 Financial Advisors's 13F filing for Q1 2026, filed 7 May 2026.